Value of ABCD2-F in Predicting Cerebral Ischemic Attacks: Three Months Follow-Up after the Primary Attack
Cerebrovascular attack (CVA) and transient ischemic attack (TIA) are major causes of emergency department visits around the globe. A significant number of these patients may experience repeat attacks if left untreated. Several risk stratifying scoring systems have been developed in recent years to point out the high risk patients. ABCD2 is based on age, blood pressure, clinical status, diabetes mellitus, and duration of symptoms and is used commonly for this purpose. In this study, we were to enhance its sensitivity and specificity with the addition of another criterion namely atrial fibrillation and making ABCD2-F. A prospective study in two hospitals was performed and 138 patients diagnosed with TIA/CVA were enrolled. Demographic, clinical, and paraclinical data of all patients were registered. All patients were followed for three months for any sign or symptom of a recurrent ischemic attack. Recurrent ischemic attacks happened in 9.4% of the patients. None of the criteria of ABCD2-F was associated with higher chance of ischemic attacks. Similarly, ABCD2-F was not different between patients with or without repeat cerebral ischemia. The addition of atrial fibrillation to ABCD2 did not enhance the accuracy of this scoring system to detect patients high risk for repeat cerebral ischemia. More studies in the future to improve sensitivity and specificity of this test are warranted.
Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000;57(3):418–20.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367(9524):1747–57.
Hackam DG, Kapral MK, Wang JT, Fang J, Hachinski V. Most stroke patients do not get a warning: a population-based cohort study. Neurology 2009;73(13):1074-6.
Rothwell P, Giles M, Flossmann E, Lovelock C, Redgrave J, Warlow C, et al. A simple tool to identify individuals at high early risk of stroke after a transient ischaemic attack: the ABCD score. Lancet 2005;366(9479):29-36.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369(9558):283–92.
Kiyohara T, Kamouchi M, Kumai Y, Ninomiya T, Hata J, Yoshimura S, et al. ABCD3 and ABCD3-I Scores Are Superior to ABCD2 Score in the Prediction of Short- and Long-Term Risks of Stroke After Transient Ischemic Attack. Stroke 2014;45(2):418-25.
Chardoli M, Khajavi A, Nouri M, Rahimi-Movaghar V. Value of ABCD2 in Predicting Early Ischemic Stroke in Patients Diagnosed with Transient Ischemic Attack. Acta Medica Iran 2013; 51(9):611-4.
De Marchis GM, Weck A, Audebert H, Benik S, Foerch C, Buhl D, et al. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke 2014; 45(10):2918-23.
Ottaviani M, Vanni S, Moroni F, Peiman N, Boddi M, Grifoni S. Urgent carotid duplex and head computed tomography versus ABCD2 score for risk stratification of patients with transient ischemic attack. Eur J Emerg Med 2014;May 20.
Asimos AW, Johnson AM, Rosamond WD, Price MF, Rose KM, Catellier D, et al. A multicenter evaluation of the ABCD2 score's accuracy for predicting early ischemic stroke in admitted patients with transient ischemic attack. Ann Emerg Med 2010;55(2):201-10.
Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Symington C, Worster A, et al. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ 2011;183(10):1137-45.
Bjorn-Mortensen K, Lynggaard F, Lynge Pedersen M. High prevalence of atrial fibrillation among Greenlanders with ischemic stroke - atrial fibrillation found in more than 30% of cases. Int J Circumpolar Health 2013;72:22628.
|Issue||Vol 54, No 6 (2016)|
|ABCD2F ABCD2 Stroke Transient ischemic attack|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|